Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van Oers

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Scandinavian Journal of Infectious Diseases|January 1, 1991
Incidence and clinical epidemiology of streptococcal septicemia during treatment of acute myeloid leukemiaH van der Lelie, R J van Ketel, A E von dem Borne, et al.
Experimental Hematology|November 1, 1993
Interleukin-6 is a survival factor for committed myeloid progenitor cellsJ M Kerst, I C Slaper-Cortenbach, C E van der Schoot, et al.
Journal of Evaluation in Clinical Practice|June 8, 2018
Analysis of the level of clinical skills of physician assistants tested with simulated intensive care patientsAnneke J A H van Vught, Geert T W J van den Brink, Murielle G E C Hilkens, et al.
British Journal of Haematology|August 25, 1999
Aberrant expression and reverse signalling of CD70 on malignant B cellsS M Lens, P Drillenburg, B F den Drijver, et al.
Blood|August 1, 1995
Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cellsA C Lankester, G M van Schijndel, C E van der Schoot, et al.
Blood|November 1, 1989
Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiationC E van der Schoot, P Jansen, M Poorter, et al.
The Journal of Infectious Diseases|June 6, 2000
High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmissionD van Baarle, E Hovenkamp, N H Dukers, et al.
British Journal of Haematology|August 29, 1998
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating studyH C van Zaanen, H M Lokhorst, L A Aarden, et al.
Lancet (London, England)|June 10, 1995
Individualised low-dose alglucerase therapy for type 1 Gaucher's diseaseC E Hollak, J M Aerts, R Goudsmit, et al.
Leukemia & Lymphoma|June 1, 2012
Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosisG Doreen te Raa, Sanne H Tonino, Ester B M Remmerswaal, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Scandinavian Journal of Infectious Diseases|January 1, 1991
Incidence and clinical epidemiology of streptococcal septicemia during treatment of acute myeloid leukemiaH van der Lelie, R J van Ketel, A E von dem Borne, et al.
Experimental Hematology|November 1, 1993
Interleukin-6 is a survival factor for committed myeloid progenitor cellsJ M Kerst, I C Slaper-Cortenbach, C E van der Schoot, et al.
Journal of Evaluation in Clinical Practice|June 8, 2018
Analysis of the level of clinical skills of physician assistants tested with simulated intensive care patientsAnneke J A H van Vught, Geert T W J van den Brink, Murielle G E C Hilkens, et al.
British Journal of Haematology|August 25, 1999
Aberrant expression and reverse signalling of CD70 on malignant B cellsS M Lens, P Drillenburg, B F den Drijver, et al.
Blood|August 1, 1995
Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cellsA C Lankester, G M van Schijndel, C E van der Schoot, et al.
Blood|November 1, 1989
Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiationC E van der Schoot, P Jansen, M Poorter, et al.
The Journal of Infectious Diseases|June 6, 2000
High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmissionD van Baarle, E Hovenkamp, N H Dukers, et al.
British Journal of Haematology|August 29, 1998
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating studyH C van Zaanen, H M Lokhorst, L A Aarden, et al.
Lancet (London, England)|June 10, 1995
Individualised low-dose alglucerase therapy for type 1 Gaucher's diseaseC E Hollak, J M Aerts, R Goudsmit, et al.
Leukemia & Lymphoma|June 1, 2012
Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosisG Doreen te Raa, Sanne H Tonino, Ester B M Remmerswaal, et al.
Pageof 13